SCHEMBL21895740

SCHEMBL21895740

CCCc1c(CC)nc(OCCCCN2CCOCC2)nc1N(CCC)CCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ SCN1A P35498 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ SCN2A Q99250 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ SCN3A Q9NY46 1/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21912197 0.83 HPGD (0.32) KCNH2HRH3TLR7PDE5A
SCHEMBL21912198 0.82 CRHR1 (0.34) CRHR1
SCHEMBL21846218 0.77 HRH3 (0.35) HRH3TLR7CRHR1
SCHEMBL25021680 0.73 CRHR1 (0.35) HRH3TLR7CRHR1
SCHEMBL19637165 0.73 HRH3 (0.45) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL21895536 0.73 TLR7 (0.38) TLR7
SCHEMBL22994702 0.71 ALDH1A1 (0.41) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL21895570 0.71 MAPK1 (0.41) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL13759198 0.65 CRHR1 (0.47) ALDH1A1CYP1A2HTR2BSIGMAR1TLR7
SCHEMBL14413070 0.65 CRHR1 (0.44) ALDH1A1MAPK1CYP1A2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback